- Data de apresentação do pedido
- 20 April 2006
- Palavras-chave
- Países de risco
- Status atual
-
Rejected
- Setor
- NCP
Alegações
Ratiopharm, a pharmaceuticals company and major producer of generic drugs, has allegedly engaged in unethical marketing practices, including bribing doctors and pharmacists in Belgium, Canada, Spain, Estonia and Germany.
Orientações relevantes da OCDE
Resultado
In June 2006, the German NCP rejected the complaint citing the lack of transnational investment. Specifically, the NCP stated the complaint only dealt with alleged misbehaviour in Germany. In July 2006, Transparency International Germany resubmitted a revised and expanded complaint
Mais detalhes
- Acusado
- Empresa em situação de infração
- Reclamantes
- Pessoas afetadas
- Data rejeitada / concluída
- 27 June 2006
Queixas relacionadas
- Gresea & Transparency International Germany vs Ratiopharm
- Transparency International Germany vs. Ratiopharm